海外の治験の状況「前立腺癌」での検索結果
167件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
- Breast Cancer;Pain;Prostate Cancer
- Australia, Peru, Puerto Rico, United States
- 1999-11-01
Not recruiting
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Peru, Puerto Rico, United States
- 2002-02-14
Not recruiting
- Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
- Prostatic Neoplasms
- Australia, Brazil, Canada, Chile, Czech Republic, Czechia, Finland, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Sweden, Taiwan, United Kingdom, United States
- 2013-12-24
Recruiting
- A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer # Prostate Cancer # Cancer of the Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Province of China, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-06-23
Not Recruiting
- Study of Psma radiopharmaceutical for diagnosis of prostate cancer recurrence
- Prostate neoplasia with local or metastatic recurrence C04.697.650 C04.697.655 C04.588.945.440.770;C04.697.650;C04.697.655;C04.588.945.440.770
- Brazil
- 2016-12-01
Authorised
- A study to provide access to continued treatment for subjects with prostate cancer who are currently participating in an enzalutamide clinical study
- metastatic castration-resistant prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Canada, Chile, Czech Republic, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Korea, Republic of, Lithuania, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slovakia, South Africa, Spain, Sweden, United Kingdom, United States
- 2016-09-29
Not recruiting
- Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer
- Prostate Cancer
- Mexico, Panama, Peru
- 2013-06-07
Recruiting
- Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)
- Prostate Cancer
- Brazil
- 2017-01-27
Not recruiting
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
- Metastatic Hormone-sensitive Prostate Cancer;Metastatic Hormone-sensitive Prostate Cancer;Metastatic Hormone-sensitive Prostate Cancer;Metastatic Hormone-sensitive Prostate Cancer
- Peru, Puerto Rico, United States
- 2006-03-29
Not Recruiting
- A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTRIC STUDY TO EVALUATE THE EFFECTS OF ROFECOXIB IN REDUCING THE RISK OF PROSTATE CANCER (VIP STUDY).
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Costa Rica, Czech Republic, Denmark, Finland, France, Germany, Greece, Israel, Italy, Netherlands, New Zealand, Portugal, Singapore, Sweden, Switzerland, United Kindgdom, United States, Venezuela
- 2003-08-28
